Your session is about to expire
← Back to Search
Gene Therapy (VTX-801) for Wilson's Disease (GATEWAY Trial)
GATEWAY Trial Summary
This trial will test if VTX-801, a gene therapy, is safe and effective in treating Wilson's Disease.
GATEWAY Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowGATEWAY Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.GATEWAY Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies available for individuals to participate in this clinical trial?
"As reported on clinicaltrials.gov, this medical study is still in the process of recruiting participants. The trial was first launched on September 3rd 2021 and underwent a revision as recently as November 4th 2022."
Does this trial welcome elderly individuals aged 85 or older?
"This clinical trial is interested in participants aged 18 and up, but no older than 65."
Are there any particular demographics that are more conducive to taking part in this medical study?
"This trial is recruiting 16 adults aged 18-65 with a documented diagnosis of Wilson's Disease who have been receiving adequate treatment for over a year. In addition to age, gender and illness criteria, participants must present no noteworthy changes in their neurological or psychological status since being diagnosed as well as stable laboratory results pertaining to copper metabolism."
Are there numerous locations in Canada executing this research project?
"The clinical trial is being conducted at University of Texas Southwestern Medical Center in Dallas, Yale University School of Medecine in New Haven, and the University of Michigan Health System in Ann Arbor. Additionally, there are 5 other sites providing access to this medication."
How many test subjects are enrolled in this clinical experiment?
"Affirmative. The clinical trial, which was first listed on September 3rd 2021, is actively bringing in participants and can be found on the website of clinicaltrials.gov. 16 individuals need to be registered from 5 separate sites for this experiment to begin."
Share this study with friends
Copy Link
Messenger